The use of Omegaven in treating parenteral nutrition-associated liver disease

@article{Park2011TheUO,
  title={The use of Omegaven in treating parenteral nutrition-associated liver disease},
  author={K T Park and Colleen Nespor and Jon F. Kerner},
  journal={Journal of Perinatology},
  year={2011},
  volume={31},
  pages={S57-S60}
}
Parenteral nutrition (PN), containing fat emulsions derived from soybean, has been implicated in the progression of PN-associated liver disease and cholestasis, particularly in infants with short bowel syndrome. Clinical use of Omegaven, a parenteral fish-oil emulsion, has been shown in recent studies to be a promising therapy to reverse liver disease and cholestasis. This review summarizes the rationale, relevant clinical investigations and future direction of Omegaven therapy for PN-dependent… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 29 REFERENCES

Impaired glucose production and b-cell dysfunction contribute to the disturbed metabolism in children with protein-energy malnutrition

FR Malone, PJ Javid, +3 authors PJ Healey
  • J Pediatr Gastroenterol Nutr
  • 2009

Effect of parenteral serum plant sterols on liver enzymes and cholesterol metabolism in a patient with short bowel syndrome.

  • Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
  • 2008